IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CLGN

Balance Sheet

(in millions USD)
MetricQ4 2025Q1 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents5.59--11.9118.9226.6722.2829.6536.2913.1517.49
Accounts Receivable0.00--0.150.25--10.160.010.010.270.28
Inventory0.57--0.440.440.711.551.431.361.080.94
Total Current Assets6.75--13.1820.3428.0234.8631.6638.2745.0949.77
Property, Plant & Equipment1.46--2.292.562.792.932.972.932.732.12
Intangible Assets0.07--0.130.160.190.220.250.240.240.16
Total Non-current Assets4.04--5.536.236.106.716.116.146.145.25
Total Assets10.79--18.7126.5734.1341.5737.7744.4151.2255.02
Short-term Debt------------0.32--0.22--
Total Current Liabilities2.67--2.973.243.252.783.112.363.012.93
Long-term Debt----------------0.03--
Total Non-current Liabilities2.03--2.282.602.542.752.382.553.092.65
Total Liabilities4.70--5.255.845.795.535.494.916.105.58
Retained Earnings(124.84)--(113.35)(105.15)(96.74)(87.67)(89.72)(80.94)(72.80)(65.95)
Total Stockholder Equity6.0812.4013.4720.7328.3436.0432.2839.5145.1249.44
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue0.180.2510.180.070.69
Cost of Revenue0.190.540.620.040.43
Gross Profit(0.01)(0.29)9.570.020.26
Research & Development2.012.702.572.601.90
Selling, General & Admin1.161.421.321.611.42
Total Operating Expenses3.174.123.894.213.33
Operating Income(3.18)(4.41)5.68(4.18)(3.06)
Net Income(3.35)(4.21)5.76(4.28)(3.04)
Basic EPS0.28(0.37)0.51(0.39)--
Diluted EPS0.28(0.37)0.49(0.39)--
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(7.18)(7.19)--7.74
Capital Expenditures0.280.480.680.37
Free Cash Flow*(7.46)(7.68)--7.37
Investing Cash Flow(0.34)(0.54)29.55(30.45)
Financing Cash Flow0.010.891.4736.87
← Scroll for more columns →

* Derived from reported values